Results 1 to 10 of about 3,607 (88)

Squamoid eccrine ductal carcinoma [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2016
Squamoid eccrine ductal carcinoma is an eccrine carcinoma subtype, and only twelve cases have been reported until now. It is a rare tumor and its histopathological diagnosis is difficult.
Maria Isabel Ramos Saraiva   +5 more
doaj   +5 more sources

Association of clinico-pathological and immunohistochemical prognostic parameters with presence of ductal carcinoma in-situ in an invasive ductal carcinoma of breast

open access: yesJournal of Pathology of Nepal, 2023
Background: The clinical outcome of breast carcinoma varies in each individual due to its molecular heterogeneity. There is a rising interest in whether the associated ductal carcinoma in-situ in invasive ductal carcinoma of breast affects the prognosis ...
Dhivya Balaiya   +2 more
doaj   +1 more source

Ductal carcinoma in situ

open access: yes, 2012
Ductal carcinoma in situ (DCIS) represents a spectrum of abnormal cells confined to the breast and is a risk factor for invasive cancer development. The incidence has increased dramatically in recent years as a result of widespread use of screening mammography.
Henry Knipe, Garth Kruger
  +6 more sources

Pancreatic ductal adenocarcinoma concomitant with pancreatic metastases of clear-cell renal cell carcinoma: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Metastatic spread to the pancreas is a rare event. Renal cell carcinoma represents one possible site of origin of pancreatic metastases. Renal cell carcinoma often metastasizes late and exclusively to the pancreas, suggesting a special role of
Lena Haeberle   +6 more
doaj   +1 more source

Mixed Mucinous Male Breast Carcinoma: A Rare Histological Variant of a Rare Disease [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2018
Male breast carcinoma is rare neoplasm, accounting for
Badareesh Lakshminarayana   +3 more
doaj   +1 more source

Breast: Ductal carcinoma [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2013
Classification Invasive ductal carcinoma is a heterogeneous group with many different subtypes, some of them extremely rare. Each of these variants is associated with another pathological presentation and with a different prognosis compared to invasive ductal carcinoma of no special type (NST).
Moelans, CB, van, Diest PJ
openaire   +4 more sources

Mucocele like Tumour of the Breast Associated with Ductal Carcinoma in situ and Focal Ductal Carcinoma: What is the Best Approach to these Patients? [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Mucocele Like Tumours (MLT) of the breast are quite rare neoplasms displaying a broad spectrum. These lesions were considered benign initially. But now, they are believed to be related to atypical ductal hyperplasia, ductal carcinoma, or mucinous ...
Serdar Altinay   +3 more
doaj   +1 more source

Profile of Digital Mammography Findings in Patients with Histopathologically Proven Ductal Carcinoma in Situ (DCIS)

open access: yesGalician Medical Journal, 2020
Breast carcinoma is a heterogeneous group of tumors with a wide spectrum of clinical presentations, lesion characterization and diagnostic evaluation.
Ankit Prabhakar   +4 more
doaj   +1 more source

The Role of Elastography in Predicting the Grade of Mammary Ductal Carcinoma

open access: yesThe Iraqi Journal of Medical Sciences, 2022
Background: Elastography is an imaging technique which has been used in the last decades and its role in breast masses characterization is well established. However, its value for predicting breast cancer grading is yet to be studied. Objective:
Taimaa T.M. Said   +2 more
doaj   +1 more source

Breast Ductal Carcinoma In Situ [PDF]

open access: yesInternational Journal of Surgical Oncology, 2012
Ductal carcinoma in situ (DCIS) of the breast is becoming one of the most important diseases diagnosed in preventive medicine screening. The current age-adjusted incidence rate of DCIS is 32.5 per 100,000 women. For women 50–64 years of age, the incidence is approximately 88 per 100,000. Currently, for every 4 diagnoses of invasive breast cancer, there
V. Sacchini   +5 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy